Grossman, S. A., Romo, C. G., Rudek, M. A., Supko, J., Fisher, J., Nabors, L. B., . . . Ye, X. (2020). Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: Conclusions from the Adult Brain Tumor Consortium’s first workshop on CNS drug delivery. Neuro Oncol.
Citación estilo ChicagoGrossman, Stuart A., et al. "Baseline Requirements for Novel Agents Being Considered for Phase II/III Brain Cancer Efficacy Trials: Conclusions From the Adult Brain Tumor Consortium’s First Workshop On CNS Drug Delivery." Neuro Oncol 2020.
Cita MLAGrossman, Stuart A., et al. "Baseline Requirements for Novel Agents Being Considered for Phase II/III Brain Cancer Efficacy Trials: Conclusions From the Adult Brain Tumor Consortium’s First Workshop On CNS Drug Delivery." Neuro Oncol 2020.